These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10892061)

  • 1. [How to solve the crisis of neurological drug therapy? ].
    Panelius M
    Duodecim; 1997; 113(18):1713, 1715. PubMed ID: 10892061
    [No Abstract]   [Full Text] [Related]  

  • 2. Learning the list. The Preferred Drug List and how it works.
    Hinkel N
    J Ark Med Soc; 2004 Dec; 101(6):168-70. PubMed ID: 15619950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testing the administration of cannabinoids in neurological diseases].
    Ideggyogy Sz; 2005 May; 58(5-6):175-6. PubMed ID: 16021965
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative to high-cost plans. Value-based option improves medication compliance.
    Dis Manag Advis; 2007 Dec; 13(12):139-42, 133. PubMed ID: 18220071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonals expand into neural disorders.
    Vastag B
    Nat Biotechnol; 2006 Jun; 24(6):595-6. PubMed ID: 16763572
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions.
    Robinson P; Anderson D; Brouwers M; Feasby TE; Hume H;
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S3-8. PubMed ID: 17397767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical care and long-term care insurance and clinical practice guideline for neurological disorders].
    Shibuya N
    Rinsho Shinkeigaku; 2003 Nov; 43(11):780-2. PubMed ID: 15152462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The blood-brain barrier is challenging drug development].
    Savolainen J; Mannila A
    Duodecim; 2005; 121(1):37-43. PubMed ID: 15712834
    [No Abstract]   [Full Text] [Related]  

  • 9. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders.
    Gold SM; Voskuhl RR
    Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological aspects of general drug therapy and the position of drug therapy in clinical neurology].
    Schulze HA
    Psychiatr Neurol Med Psychol (Leipz); 1971 Nov; 23(11):610-6. PubMed ID: 5145538
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evidence-based treatment guidelines].
    Mäkelä M; Kunnamo I
    Duodecim; 1997; 113(1):19-22. PubMed ID: 11370050
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of immunoglobulin in the therapy of neurological illnesses].
    Elovaara I; Färkkilä M; Hietaharju A; Pirttilä T
    Duodecim; 2001; 117(10):1033-41; quiz 1041, 1081. PubMed ID: 12116461
    [No Abstract]   [Full Text] [Related]  

  • 14. Descriptions of treatment effects in neurology textbooks recommended for medical students.
    Mattsson P; Hallberg M
    Acta Neurol Scand; 2004 Dec; 110(6):412-4. PubMed ID: 15527456
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult neurogenesis pharmacology in neurological diseases and disorders.
    Taupin P
    Expert Rev Neurother; 2008 Feb; 8(2):311-20. PubMed ID: 18271715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis: old medicine with new promise for neurological disorders.
    Carter GT; Weydt P
    Curr Opin Investig Drugs; 2002 Mar; 3(3):437-40. PubMed ID: 12054093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cost of neurological disease].
    Irimia Sieira P
    Neurologia; 2008; 23(1):1-3. PubMed ID: 18365772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based coverage decisions? Primum non nocere.
    McElwee NE; Ho SY; McGuigan KA; Horn ML
    Health Aff (Millwood); 2006; 25(4):W279-82. PubMed ID: 16757489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant diseases.
    Rainsford KD
    Inflammopharmacology; 2004; 12(3):211-3. PubMed ID: 15527543
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to the expertise: procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen.
    Koch K; Lange S
    Eur J Health Econ; 2009 May; 10(2):233-6. PubMed ID: 19123011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.